Filing Details
- Accession Number:
- 0001628280-21-018433
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-13 08:12:36
- Reporting Period:
- 2021-09-10
- Accepted Time:
- 2021-09-13 08:12:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1213037 | Cardiff Oncology Inc. | CRDF | Biological Products, (No Disgnostic Substances) (2836) | 272004382 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1463151 | E. James Levine | C/O Cardiff Oncology, Inc. 11055 Flitkote Ave San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-10 | 5,000 | $6.62 | 5,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 5,000 | $6.75 | 10,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 10,000 | $6.38 | 20,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 5,000 | $6.35 | 25,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 5,000 | $6.32 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
